Literature DB >> 6813147

The hyperprolactinemic polycystic ovary syndrome may not be an distinct entity.

B Corenblum, P J Taylor.   

Abstract

Thirteen women with hyperprolactinemia and clinical stigmata of the polycystic ovary syndrome (PCO) had their serum prolactin (PRL) response to thyrotropin-releasing hormon (TRH) compared with two other groups of PCO. One PCO group had an elevated ratio of basal luteinizing hormone (LH) to follicle-stimulating hormone (FSH), and another had a normal ratio of basal LH to FSH. The PRL response to TRH was similar in hyperprolactinemic PCO and elevated LH PCO, and both were significantly greater than normal LH PCO and normal women. This suggests the hyperprolactinemic polycystic ovary (HPCO) is probably produced by similar central and/or peripheral mechanisms that result in the production of an elevated serum LH. These two features are probably associated in a common pathophysiologic mechanism. The HPCO syndrome does not appear to be a distinct entity but clinically must be differentiated from other causes of mild hyperprolactinemia.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6813147

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  4 in total

1.  Acute effects of L-dopa and bromocriptine on serum PRL, LH and FSH levels in patients with hyperprolactinemic and normoprolactinemic polycystic ovary syndrome.

Authors:  G M Prelević; M I Würzburger; L A Perić
Journal:  J Endocrinol Invest       Date:  1987-08       Impact factor: 4.256

2.  Prolactin pulsatility in polycystic ovarian disease.

Authors:  T Laatikainen; A Tulenheimo
Journal:  J Endocrinol Invest       Date:  1985-04       Impact factor: 4.256

3.  Metoclopramide effect on serum prolactin LH and FSH in patients with polycystic ovary syndrome.

Authors:  G M Prelević; M I Würzburger; L A Perić
Journal:  J Endocrinol Invest       Date:  1988-04       Impact factor: 4.256

4.  Cabergoline plus metformin therapy effects on menstrual irregularity and androgen system in polycystic ovary syndrome women with hyperprolactinemia.

Authors:  Azam Ghaneei; Akram Jowkar; Mohammad Reza Hasani Ghavam; Mohammad Ebrahim Ghaneei
Journal:  Iran J Reprod Med       Date:  2015-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.